Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Asset Writedowns and Impairment (2023 - 2025)

Core Laboratories' Asset Writedowns and Impairment history spans 3 years, with the latest figure at -$2.4 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment fell 224.87% year-over-year to -$2.4 million; the TTM value through Dec 2025 reached $34000.0, down 98.84%, while the annual FY2025 figure was $34000.0, 98.84% down from the prior year.
  • Asset Writedowns and Impairment reached -$2.4 million in Q4 2025 per CLB's latest filing, down from $809000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.9 million in Q4 2024 to a low of -$2.4 million in Q4 2025.
  • Average Asset Writedowns and Impairment over 3 years is $456666.7, with a median of $809000.0 recorded in 2025.
  • The largest YoY upside for Asset Writedowns and Impairment was 951.58% in 2025 against a maximum downside of 224.87% in 2025.
  • A 3-year view of Asset Writedowns and Impairment shows it stood at $128000.0 in 2023, then soared by 1398.44% to $1.9 million in 2024, then crashed by 224.87% to -$2.4 million in 2025.
  • Per Business Quant, the three most recent readings for CLB's Asset Writedowns and Impairment are -$2.4 million (Q4 2025), $809000.0 (Q3 2025), and $1.6 million (Q2 2025).